Ptc Therapeutics, Inc. · NASDAQ:PTCT

Boulding Mark Elliott sold 192 Ptc Therapeutics, Inc. shares (Form 4)

Traded Oct 9, 2026 · Filed Oct 13, 2026

On Oct 9, 2026, Boulding Mark Elliott (EXEC. VP AND CLO) sold 192 Ptc Therapeutics, Inc. shares at US$64.26 for US$12,338 under a trading plan, leaving 105,272 shares. Filed Oct 13, 2026 (Form 4).

Sold
192 shares
Price
US$64.26
Value
US$12,338
Holding after
105,272 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EXEC. VP AND CLO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 9, 2026Common StockOption exercise192US$39.42105,464Direct
Oct 9, 2026Common StockSale192US$64.26105,272Direct

Source

View original at SEC

Related